CRNX ▼ -0.0% - Crinetics Pharmaceuticals, Inc. $CRNX Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team Vertex Pharmaceuticals completed its acquisition of Crinetics Pharmaceuticals, a move that consolidates Crinetics' pipeline of rare disease treatments into Vertex's portfolio. The deal marks the end of Crinetics as an independent company, with Vertex also announcing changes to its executive leadership team as part of the integration. 01-SEP-2026 09:04 AM ET